Naranjo Causality Assessment Scale
Adverse drug reactions (ADRs) pose a significant challenge in clinical practice, necessitating a systematic approach to determining whether a drug is responsible for an observed reaction. The Naranjo Causality Assessment Scale (NCAS) is a widely used tool that helps healthcare professionals assess the likelihood of a causal relationship between a drug and an adverse event.
What is the Naranjo Causality Assessment Scale?
The Naranjo Causality Assessment Scale is a structured questionnaire designed to evaluate the probability of a drug-induced adverse reaction. It was developed in 1981 by Naranjo et al. to provide a standardized approach for assessing ADRs. The scale consists of ten objective questions, each with a specific score contributing to the overall causality assessment.
Key Features of the Naranjo Scale
-
- Standardized Approach: Provides a systematic and reproducible method to assess ADRs.
- Questionnaire-Based: Consists of 10 questions addressing different aspects of drug-reaction relationships.
The Naranjo Questionnaire
Each question in the Naranjo scale has three possible answers: Yes, No, or Do Not Know, with corresponding scores:
- Are there previous conclusive reports on this reaction? (+1 / 0 / 0)
- Did the adverse event appear after the suspected drug was administered? (+2 / -1 / 0)
- Did the adverse reaction improve when the drug was discontinued (dechallenge)? (+1 / 0 / 0)
- Did the adverse event reappear upon re-administration (rechallenge)? (+2 / -1 / 0)
- Are there alternative causes (other than the drug) that could solely explain the reaction? (-1 / +2 / 0)
- Did the reaction appear when a placebo was given? (-1 / +1 / 0)
- Was the drug detected in the blood (or other biological fluids) at concentrations known to be toxic? (+1 / 0 / 0)
- Was the reaction more severe when the dose was increased or less severe when the dose was decreased? (+1 / 0 / 0)
- Did the patient have a similar reaction to the same or similar drugs in the past? (+1 / 0 / 0)
- Was the adverse event confirmed by objective evidence? (+1 / 0 / 0)
Interpretation of Scores
The total score classifies the causality as follows:
- Definite (≥ 9 points): The drug is the probable cause of the reaction.
- Probable (5-8 points): The drug is likely responsible for the reaction.
- Possible (1-4 points): The drug may be related to the reaction.
- Doubtful (≤ 0 points): The drug is unlikely to be responsible.
Advantages of the Naranjo Scale
- Systematic and standardized approach for ADR assessment.
- Simple and easy to use in clinical and research settings.
- Minimizes subjectivity by using predefined criteria.
- Applicable to a wide range of drugs and adverse effects.
Limitations of the Naranjo Scale
- Does not consider patient-specific factors such as genetics and comorbidities.
- Limited in detecting rare or delayed ADRs.
- Relies on clinical judgment, which may vary among assessors.
- Not suitable for all types of ADRs, especially those without clear rechallenge data.
Conclusion
The Naranjo Causality Assessment Scale is a valuable tool for evaluating drug-related adverse events. While it provides a structured method for assessment, it should be used alongside clinical expertise, patient history, and other causality assessment tools to make well-informed decisions in pharmacovigilance and patient care.
